June 2016 Issue Table Of Contents

From The Editor

• Who Will Move Biopharma Beyond The Cutting Edge?

Feature Articles

• Takeda’s New Plans For Worldwide Growth
• How To Achieve Excellence In A Biopharma Supply Chain
• Developing New Therapeutics For Progressive MS

Capitol Perspectives

• Congress Rebukes CMS On Part B Demo

CEO Corner

• In A Political Year, We Need To Remember The Value Of Pharma/Bio

Inside The Industry

• Pursuing Drug Development Against Investors’ Advice
• Alios BioPharma: From Startup To Big Pharma
• How Agile Therapeutics Got Through A Critical Phase 3 Trial

Leadership Lessons

• Outside Perspectives On Change

Ask The Board

• What Nonbiopharma Company Do You Anticipate As Being The Biggest Disruptor To Our Industry?
• What Do You Think Will Be The End Result Of The Bullying Of Biopharma?
• What Are Your Top Leadership Books To Read, And Why?